This AANHPI Heritage Month, we celebrate the contributions, perspectives, & impact of Asian American, Native Hawaiian, & Pacific Islander communities across science, healthcare, & beyond. Thank you to those who drive science & innovation forward every day. #AANHPI

4,812,000 Cancer deaths have been averted since 1991*. This National Cancer Research Month, we recognize the researchers and clinicians advancing oncology and the progress shaping earlier detection, better treatments, and prevention. *American Cancer Society, 2025

World DNA Day is more than a milestone. It reflects a global community turning generic insight into real-world impact. Each sequence moves us forward. Efforts like SpecimenSeq help strengthen the data foundations, driving progress in personalized medicine. lnkd.in/euXMfC5S

Our Newtown lab’s My Green Lab® Certification was a '25 highlight! In 2026 the team has re-enrolled in the Freezer Challenge, launched a Green ACTION Calendar, & will soon get a Green Snack Vending Machine with healthier options. #EarthDay lnkd.in/eysXPyWz

Our latest blog breaks down what’s driving this shift and what it means for development teams navigating an increasingly compressed timeline. Read the full analysis to see what has changed and what comes next. lnkd.in/eCkq_J55

1st ever use of CAR-T in a neurodegenerative setting. CD4+ CAR-T cells targeting amyloid-beta plaques and improved brain health in Alzheimer’s mouse models. If this translates to humans, it opens a new frontier for cell-based immunotherapies. lnkd.in/g2wEF3PM

New Nature paper demonstrates proof of concept for in vivo CAR-T using dual delivery of CRISPR-Cas9 and CAR to improve precise delivery and reduce off-target risk. Early days, but a big step toward lower-cost, more accessible cell therapies. lnkd.in/eei8cc7b

Recent FDA rare disease wins are moving the needle for patients. Denali’s Avlayah for Hunter syndrome was supported by surrogate biomarker reduction in CSF heparan sulfate, & Rocket Pharma’s  Kresladi  for LAD‑1 is the 1st CGT approval of '26. lnkd.in/etcpqif9

What’s next in oncology research? Discovery is presenting it at #AACR2026 in San Diego! From ADC evaluation to proteogenomics and tumor immunology, join our poster session April 19 & 22 to see the latest data. More details: lnkd.in/e2sVExFC

Deep proteomic insight starts with the right enrichment strategy. Dr. Jessica Moore explains how the SEER Proteograph workflow enables broad protein discovery from complex biofluids, powering biomarkers and deep LC-MS analysis. lnkd.in/gT-Vf5_v

Legacy biospecimens hold decades of insight but are often underused. The Discovery Legacy Program gives researchers access to high‑quality legacy specimens for studying disease progression, treatment response, and long‑term outcomes. Read our latest blog: lnkd.in/ew2T8wuV

Discovery Life Sciences + Mindpeak brings AI-powered precision to pathology by enhancing consistency, reducing risk, & strengthening confidence in biomarker driven decisions. Read the press release: lnkd.in/eFcGd69p

Automation is key to scalable and reproducible proteomics. In the latest video in our series, Dr. Jessica Moore explains how the SEER Proteograph and Agilent AssayMAP Bravo enable scalable sample prep and deeper proteome coverage for large, complex studies.

March marks #WomensHistoryMonth! From human resources and accounting to quality assurance and pathology, women play a vital role in our science community. Swipe to see how Discovery’s very own Annette Mühleisen and Mandy Andrade contribute to pushing the world of science forward!

Oncology biospecimens + precision biomarker services — under one roof. See us at #AACR26, booth #3038 → San Diego, April 17–22 Book time with our team: lnkd.in/e2sVExFC

How do IVDR regulations impact clinical trial assay development? Join Discovery's Scott Reid, VP & Global Head of Companion Diagnostic Services during his presentation at World CB & CDx Summit EU on Tuesday, 31 March at 5:20 Connect with our experts: lnkd.in/egfs3rRv

March marks #WomensHistoryMonth! From human resources and accounting to quality assurance and pathology, women play a vital role in our science community. Swipe to see how Discovery’s very own Tamara Bowles and Mimi Lo contribute to pushing the world of science forward!

Autoimmune research doesn’t follow a standard playbook. Read how Discovery supports autoimmune research. lnkd.in/eXT7-cM8

Limited seats. Limitless impact. Join Discovery on the B4 Tour, an in-person 3-city series exploring innovations in genomics, proteomics, molecular pathology, & cell biology powering precision medicine. Register today. lnkd.in/eW2qhen4

New app note: 3D hepatocyte spheroids deliver longer-lived, human-relevant metabolism for low-clearance drug compounds. Explore our workflow + performance data: lnkd.in/euXM7qgt